Barry Rodgers‐Gray
About
Barry Rodgers‐Gray is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Surgery.
According to data from OpenAlex, Barry Rodgers‐Gray has authored 24 papers receiving a total of 261 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Epidemiology, 16 papers in Pulmonary and Respiratory Medicine and 11 papers in Surgery. Recurrent topics in Barry Rodgers‐Gray's work include Respiratory viral infections research (19 papers), Neonatal Respiratory Health Research (14 papers) and Congenital Diaphragmatic Hernia Studies (9 papers). Barry Rodgers‐Gray is often cited by papers focused on Respiratory viral infections research (19 papers), Neonatal Respiratory Health Research (14 papers) and Congenital Diaphragmatic Hernia Studies (9 papers). Barry Rodgers‐Gray collaborates with scholars based in Spain, Canada and United States. Barry Rodgers‐Gray's co-authors include John Fullarton, Xavier Carbonell‐Estrany, Bosco Paes, E. Grubb, Scot Buchan, Marcello Lanari, Evan J. Anderson, Maarten O. Blanken, Margaret Sheridan‐Pereira and Richard Thwaites and has published in prestigious journals such as PLoS ONE, The Journal of Infectious Diseases and Alimentary Pharmacology & Therapeutics.
In The Last Decade
Barry Rodgers‐Gray
20 papers receiving 252 citations
Peers
Barry Rodgers‐Gray
O. Nieto Spain
David Lacy United Kingdom
Giulia Cangiano Italy
Alejandro Colom Argentina
Elizabeth Walsh United States
Rohan Malik India
Marta Ruiz de Valbuena Spain
Stine Bang Andersen Denmark
Helen Stevens United Kingdom
Edwin Rietveld Netherlands
Citations per year, relative to Barry Rodgers‐Gray Barry Rodgers‐Gray (= 1×)
peers
O. Nieto
Countries citing papers authored by Barry Rodgers‐Gray
Since
Specialization
Citations
This map shows the geographic impact of Barry Rodgers‐Gray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barry Rodgers‐Gray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barry Rodgers‐Gray more than expected).
Fields of papers citing papers by Barry Rodgers‐Gray
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Barry Rodgers‐Gray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barry Rodgers‐Gray. The network helps show where Barry Rodgers‐Gray may publish in the future.
Co-authorship network of co-authors of Barry Rodgers‐Gray
This figure shows the co-authorship network connecting the top 25 collaborators of Barry Rodgers‐Gray. A scholar is included among the top collaborators of Barry Rodgers‐Gray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barry Rodgers‐Gray. Barry Rodgers‐Gray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Genova, Carlo, Federico Cappuzzo, Giorgio Minotti, et al.. (2025). The effects of race on anti-PD-(L)1 monoclonal antibodies in non-small cell lung cancer: A systematic literature review and meta-analysis. Critical Reviews in Oncology/Hematology. 214. 104812–104812.
2.
Kang, Ji‐Man, Xavier Carbonell‐Estrany, Bosco Paes, et al.. (2025). Optimizing risk factors to guide COST‐effective use of palivizumab in KOREAN infants. Pediatrics International. 67(1). e70021–e70021.
3.
Billard, Marie‐Noëlle, Joanne Wildenbeest, Ryszard Kole, et al.. (2025). Post-Pandemic Dynamics of the Global Circulation of Human Metapneumovirus and Respiratory Syncytial Virus. The Journal of Infectious Diseases. 232(Supplement_1). S10–S18.
4.
Bracht, Marianne, et al.. (2025). Parental Knowledge and Understanding of Respiratory Syncytial Virus and How to Decrease the Risk of Infection: The Canadian Premature Babies Foundation Survey 2023. Neonatal Network The Journal of Neonatal Nursing. 44(3). 187–196.
5.
Paes, Bosco, Marcello Lanari, Barry Rodgers‐Gray, John Fullarton, & Xavier Carbonell‐Estrany. (2024). Opinion: The optimal use of risk factors to guide palivizumab prophylaxis against severe respiratory syncytial virus infection in moderate-to-late preterm infants. Frontiers in Pediatrics. 12. 1343960–1343960.
6.
Thampi, Nisha, et al.. (2024). Perspective: the potential of wastewater-based surveillance as an economically feasible game changer in reducing the global burden of pediatric respiratory syncytial virus infection. Frontiers in Public Health. 11. 1316531–1316531.
7.
Ravasio, Roberto, John Fullarton, Paolo Manzoni, et al.. (2023). A new cost-utility analysis assessing risk factor-guided prophylaxis with palivizumab for the prevention of severe respiratory syncytial virus infection in Italian infants born at 29–35 weeks’ gestational age. PLoS ONE. 18(8). e0289828–e0289828.
8.
Rodgers‐Gray, Barry, et al.. (2023). Impact of using the International Risk Scoring Tool on the cost-utility of palivizumab for preventing severe respiratory syncytial virus infection in Canadian moderate-to-late preterm infants. Journal of Medical Economics. 26(1). 630–643.
9.
Bracht, Marianne, et al.. (2023). Understanding Policy Decisions and Their Implications Regarding Preventive Interventions for Respiratory Syncytial Virus (RSV) Infection in Canadian Infants: A Primer for Nurses. Neonatal Network The Journal of Neonatal Nursing. 42(5). 291–302.
10.
Paes, Bosco, John Fullarton, Barry Rodgers‐Gray, & Xavier Carbonell‐Estrany. (2021). Adoption in Canada of an international risk scoring tool to predict respiratory syncytial virus hospitalization in moderate-to-late preterm infants. Current Medical Research and Opinion. 37(7). 1149–1153.
11.
Carbonell‐Estrany, Xavier, et al.. (2020). Provision of Additional Risk Factors to Facilitate Country Utilization of the Risk Scoring Tool for Predicting Respiratory Syncytial Virus Hospitalization in Moderate-to-Late Preterm Infants. American Journal of Perinatology. 37.
12.
Lanari, Marcello, Evan J. Anderson, Margaret Sheridan‐Pereira, et al.. (2020). Burden of respiratory syncytial virus hospitalisation among infants born at 32–35 weeks' gestational age in the Northern Hemisphere: pooled analysis of seven studies. Epidemiology and Infection. 148. e170–e170.
13.
Carbonell‐Estrany, Xavier, Barry Rodgers‐Gray, & Bosco Paes. (2020). Challenges in the prevention or treatment of RSV with emerging new agents in children from low- and middle-income countries. Expert Review of Anti-infective Therapy. 19(4). 419–441.
14.
Irving, Peter M., Johan Burisch, Richard Driscoll, et al.. (2018). IBD2020 global forum: results of an international patient survey on quality of care. Intestinal Research. 16(4). 537–545.
15.
Carbonell‐Estrany, Xavier, John Fullarton, Barry Rodgers‐Gray, et al.. (2018). Interaction between healthcare professionals and parents is a key determinant of parental distress during childhood hospitalisation for respiratory syncytial virus infection (European RSV Outcomes Study [EROS ]). Acta Paediatrica. 107(5). 854–860.
16.
Manzoni, Paolo, Gerard R. Martin, Manuel Sánchez Luna, et al.. (2017). Pulse oximetry screening for critical congenital heart defects: a European consensus statement. The Lancet Child & Adolescent Health. 1(2). 88–90.
17.
Carbonell‐Estrany, Xavier, John Fullarton, Katherine Gooch, et al.. (2016). The influence of birth weight amongst 33–35 weeks gestational age (wGA) infants on the risk of respiratory syncytial virus (RSV) hospitalisation: a pooled analysis. The Journal of Maternal-Fetal & Neonatal Medicine. 30(2). 134–140.
18.
Anderson, Evan J., Xavier Carbonell‐Estrany, Maarten O. Blanken, et al.. (2016). Burden of Severe Respiratory Syncytial Virus Disease Among 33–35 Weeks’ Gestational Age Infants Born During Multiple Respiratory Syncytial Virus Seasons. The Pediatric Infectious Disease Journal. 36(2). 160–167.
19.
Carbonell‐Estrany, Xavier, John Fullarton, Barry Rodgers‐Gray, et al.. (2014). Can we improve the targeting of respiratory syncytial virus (RSV) prophylaxis in infants born 32–35 weeks’ gestational age with more informed use of risk factors?. The Journal of Maternal-Fetal & Neonatal Medicine. 28(10). 1133–1141.
20.
Steinhart, A. Hillary, et al.. (2007). Systematic review: the potential influence of mesalazine formulation on maintenance of remission in Crohn’s disease. Alimentary Pharmacology & Therapeutics. 25(12). 1389–1399.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by O. Nieto Breakdown of academic impact, for papers by David Lacy Breakdown of academic impact, for papers by Giulia Cangiano Breakdown of academic impact, for papers by Alejandro Colom Breakdown of academic impact, for papers by Elizabeth Walsh Breakdown of academic impact, for papers by Rohan Malik Breakdown of academic impact, for papers by Marta Ruiz de Valbuena Breakdown of academic impact, for papers by Stine Bang Andersen Breakdown of academic impact, for papers by Helen Stevens Breakdown of academic impact, for papers by Edwin Rietveld